Internal Medicine, Infectious Disease · Bakersfield, CA
NPI
1629004957
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
3535 San Dimas Street, Suite 24
Bakersfield, CA, 93389
Phone (661) 324-3128
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
595 services
Medicare patients, 2024
220
Average age 67
Drug cost, 2024
$5.4M
2,717 prescriptions
Company payments, 2025
$61K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Franco A Felizarta was code 99213 (office e&m - established), 202 times for 124 patients. In total Franco A Felizarta billed 595 services in 9 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 202 | 124 | $49.06 | $9,910 |
| 99214 Office E&M - Established | Office | 75 | 44 | $76.50 | $5,737 |
| 99212 Office E&M - Established | Facility | 64 | 30 | $27.85 | $1,782 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 19 | $54.95 | $2,748 |
| 99213 Office E&M - Established | Facility | 47 | 24 | $52.15 | $2,451 |
| 99203 Office E&M - New | Office | 47 | 47 | $75.47 | $3,547 |
| 99212 Office E&M - Established | Office | 39 | 29 | $26.64 | $1,039 |
| 99223 Hospital E&M - Initial | Facility | 22 | 21 | $136.14 | $2,995 |
| 99204 Office E&M - New | Facility | 16 | 16 | $105.39 | $1,686 |
| 99203 Office E&M - New | Facility | 13 | 13 | $64.54 | $839 |
| 99204 Office E&M - New | Office | 13 | 13 | $111.76 | $1,453 |
By year: 2022 $30K for 533 services; 2023 $43K for 768 services; 2024 $35K for 595 services.
Medicare prescription drug claims, 2024
In 2024, the drug Franco A Felizarta prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 351 prescriptions and refills. In total Franco A Felizarta wrote 2,717 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 351 | 351 | 44 | $1.4M |
| Juluca Dolutegravir/Rilpivirine | 170 | 170 | 12 | $458K |
| Fluconazole Generic | 161 | 184 | 37 | $13K |
| Prezcobix Darunavir/Cobicistat | 156 | 156 | 19 | $384K |
| Doxycycline Hyclate Generic | 124 | 130 | 41 | $2,111 |
| Isentress Hd Raltegravir Potassium | 97 | 97 | 12 | $198K |
| Estradiol Generic | 96 | 189 | 34 | $4,529 |
| Cefepime Hcl Generic | 90 | 90 | 13 | $14K |
| Tivicay Dolutegravir Sodium | 89 | 89 | Under 11 | $225K |
| Dovato Dolutegravir Sodium/Lamivudine | 86 | 86 | Under 11 | $259K |
| Descovy Emtricitabine/Tenofov Alafenam | 81 | 81 | Under 11 | $183K |
| Sodium Chloride 0.9 % Sodium Chloride | 73 | 73 | 13 | $6,285 |
| Delstrigo Doravirine/Lamivu/Tenofov Diso | 72 | 87 | Under 11 | $232K |
| Meropenem Generic | 68 | 68 | 11 | $15K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 63 | 63 | Under 11 | $229K |
Brand drugs: 1,509 claims; generic drugs: 1,208 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Franco A Felizarta $61K ($57K in general payments such as food, travel and fees and $3,488 for research) from 7 companies. The largest payer was Gilead Sciences, Inc. with $28K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.